MIDFOINT

MIDFOINT is a pioneering monophasic hyaluronic acid (HA) filler developed by DNC, specifically designed for delicate areas of the face such as under the eyes and lips. The formulation aims to provide natural volume while addressing issues like wrinkles and volume loss. This product represents a significant advancement in the field of medical aesthetics, focusing on achieving a balance between softness, elasticity, and durability.

Characteristics of MIDFOINT

1. Monophasic vs. Biphasic Fillers: Unlike biphasic fillers that have distinct phases leading to a more pronounced volume effect, monophasic fillers like MIDFOINT are characterized by their uniform particle distribution. This results in high elasticity and a smoother injection experience. The unique formulation allows for better integration into the skin, minimizing the sensation of foreign material post-injection.

2. Physical Properties: MIDFOINT features finely uniform particles that enhance its cohesiveness and softness. These properties facilitate easy molding during application, which is crucial for achieving natural-looking results in areas with thin skin. The filler maintains its shape without unwanted movement or flow after injection due to its specific viscoelastic characteristics.

3. Research and Development: The creation of MIDFOINT involved three years of dedicated research aimed at overcoming challenges faced by existing fillers in terms of viscoelasticity, durability, and volume retention. The result is a product that combines soft viscoelasticity with effective volumization capabilities.

4. Clinical Applications: MIDFOINT is particularly effective in treating fine lines and restoring lost volume around delicate facial areas. Its formulation allows practitioners to achieve precise results while ensuring patient comfort during the procedure.

5. Storage Modulus and Viscosity: The storage modulus (G’) indicates the filler’s elasticity, while the loss modulus (G’’) reflects its viscosity characteristics. A favorable tan delta ratio (G’’/G’) ensures that MIDFOINT is neither too watery nor too hard, providing an optimal injection experience.

6. Market Positioning: DNC aims for MIDFOINT to become a leading choice among monophasic fillers in Korea’s competitive market landscape, emphasizing quality and efficacy as key differentiators from other products available.

Storage Ability of MIDFOINT
MIDFOINT, like other hyaluronic acid fillers, requires specific storage conditions to maintain its efficacy and safety. It should be stored in a cool, dry place away from direct sunlight and extreme temperatures. The recommended storage temperature is typically between 2°C to 25°C (36°F to 77°F). Proper storage is crucial as exposure to high temperatures or direct light can degrade the product, affecting its performance during injection.

Guidelines for Use
When using MIDFOINT, practitioners must adhere to established guidelines to ensure patient safety and optimal results. These guidelines include:

1. Pre-Procedure Assessment: A thorough assessment of the patient’s medical history and aesthetic goals should be conducted before treatment.
2. Injection Technique: Practitioners should use appropriate techniques such as linear threading or micro-droplet methods to achieve even distribution of the filler.
3. Hygiene Practices: Maintaining strict hygiene protocols is essential to prevent infections. This includes using sterile equipment and disinfecting the injection site.
4. Post-Procedure Care: Patients should be advised on aftercare practices, including avoiding strenuous activities and excessive sun exposure for a specified period post-injection.

Components of MIDFOINT
MIDFOINT primarily consists of hyaluronic acid, which is a naturally occurring substance in the body known for its hydrating properties. The formulation may also include:

• Cross-linking Agents: These are used to enhance the stability and longevity of the filler within the tissue.
• Buffering Agents: To maintain pH balance and improve comfort during injection.
• Preservatives: Although many modern fillers are preservative-free, some formulations may contain preservatives to extend shelf life.

The exact composition can vary based on proprietary formulations by DNC but generally focuses on achieving optimal viscoelastic properties.

Indications for Use
MIDFOINT is indicated for various aesthetic applications, particularly in delicate facial areas where subtle volume enhancement is desired. Common indications include:

1. Under-Eye Treatment: To reduce hollowness and dark circles.
2. Lip Enhancement: For adding volume and definition without compromising natural appearance.
3. Fine Lines and Wrinkles: Effective in treating superficial lines around the mouth and eyes.
4. Facial Contouring: Used for enhancing cheekbones or jawline definition while maintaining a natural look.

It is important that practitioners evaluate each patient’s individual needs when considering MIDFOINT for treatment.

Who Can Use MIDFOINT?
MIDFOINT can be administered by qualified healthcare professionals trained in aesthetic procedures, including:

1. Dermatologists
2. Plastic Surgeons
3. Cosmetic Physicians
4. Nurse Practitioners with specialized training

These professionals must have a comprehensive understanding of facial anatomy, injection techniques, and management of potential complications associated with dermal fillers.